Breaking news FDA approves Biogen-Eisai Alzheimer drug Leqembi Luglio 6, 2023 The United States Food and Drug Administration (FDA) announced on Thursday it granted traditional approval to the Alzheimer treatment Leqembi developed by Eisai Co. Ltd. and Biogen Inc. “Today&r…
